Magellan Health Company Profile (NASDAQ:MGLN)

About Magellan Health (NASDAQ:MGLN)

Magellan Health logoMagellan Health, Inc. is engaged in the healthcare management business. The Company's segments include Healthcare, Pharmacy Management and Corporate. It is focused on managing special populations, complete pharmacy benefits and other specialty areas of healthcare. Its Healthcare includes its management of behavioral healthcare services and employee assistance program (EAP) services, management of other specialty areas, including diagnostic imaging and musculoskeletal management, and the integrated management of physical, behavioral and pharmaceutical healthcare for special populations, delivered through Magellan Complete Care (MCC). Its Pharmacy Management segment consists of products and solutions that provide clinical and financial management of pharmaceuticals paid under medical and pharmacy benefit programs. Its Corporate segment consists primarily of operational support functions. It provides services to health plans and other managed care organizations (MCOs).

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Health Care Plans
  • Sub-Industry: Managed Health Care
  • Symbol: NASDAQ:MGLN
  • CUSIP: 55907920
  • Web: www.magellanhealth.com
Capitalization:
  • Market Cap: $1.72 billion
  • Outstanding Shares: 23,716,000
Average Prices:
  • 50 Day Moving Avg: $70.50
  • 200 Day Moving Avg: $72.05
  • 52 Week Range: $49.50 - $84.71
P/E:
  • Trailing P/E Ratio: 21.21
  • Foreward P/E Ratio: 12.88
  • P/E Growth: -10.45
Sales & Book Value:
  • Annual Revenue: $5.03 billion
  • Price / Sales: 0.34
  • Book Value: $47.71 per share
  • Price / Book: 1.52
Profitability:
  • EBIDTA: $245.9 million
  • Net Margins: 1.64%
  • Return on Equity: 9.05%
  • Return on Assets: 4.21%
Debt:
  • Debt-to-Equity Ratio: 0.18%
  • Current Ratio: 1.25%
  • Quick Ratio: 1.19%
Misc:
  • Average Volume: 139,808 shs.
  • Beta: 0.63
  • Short Ratio: 1.26
 

Frequently Asked Questions for Magellan Health (NASDAQ:MGLN)

What is Magellan Health's stock symbol?

Magellan Health trades on the NASDAQ under the ticker symbol "MGLN."

How were Magellan Health's earnings last quarter?

Magellan Health, Inc. (NASDAQ:MGLN) released its quarterly earnings results on Wednesday, April, 26th. The company reported $0.74 EPS for the quarter, beating the consensus estimate of $0.70 by $0.04. The firm earned $1.31 billion during the quarter, compared to the consensus estimate of $1.33 billion. Magellan Health had a net margin of 1.64% and a return on equity of 9.05%. Magellan Health's revenue for the quarter was up 16.9% on a year-over-year basis. During the same quarter in the prior year, the firm earned $0.79 EPS. View Magellan Health's Earnings History.

When will Magellan Health make its next earnings announcement?

Magellan Health is scheduled to release their next quarterly earnings announcement on Thursday, July, 27th 2017. View Earnings Estimates for Magellan Health.

What guidance has Magellan Health issued on next quarter's earnings?

Magellan Health issued an update on its FY17 earnings guidance on Wednesday, April, 26th. The company provided earnings per share guidance of $5.08-5.99 for the period, compared to the Thomson Reuters consensus estimate of $5.37. The company issued revenue guidance of $5.795-6.095 billion, compared to the consensus revenue estimate of $5.86 billion.

Where is Magellan Health's stock going? Where will Magellan Health's stock price be in 2017?

4 equities research analysts have issued 1-year price objectives for Magellan Health's shares. Their forecasts range from $69.00 to $88.00. On average, they expect Magellan Health's stock price to reach $76.67 in the next twelve months. View Analyst Ratings for Magellan Health.

What are analysts saying about Magellan Health stock?

Here are some recent quotes from research analysts about Magellan Health stock:

  • 1. According to Zacks Investment Research, "Magellan Health Services is the country's leading behavioral managed care organization. Its customers include health plans, corporations and government agencies. " (4/27/2017)
  • 2. Jefferies Group LLC analysts commented, "We believe mixed 4Q results and a small EPS guidance reduction (share count related) on the heels of MGLN's 50%+ surge (vs S&P's +10%) since early November are causing shares to pull back today (down 7-8% vs S&P's -0.2%). 4Q16 revenue was soft, but that's largely due to a short delay in starting new work. We think fundamentals remain broadly strong and remain Buy rated, but we modestly reduce our earnings projections and PT for higher Pharmacy uncertainty." (2/24/2017)

Are investors shorting Magellan Health?

Magellan Health saw a increase in short interest during the month of May. As of May 31st, there was short interest totalling 201,029 shares, an increase of 6.3% from the May 15th total of 189,129 shares. Based on an average daily trading volume, of 158,578 shares, the days-to-cover ratio is presently 1.3 days.

Who are some of Magellan Health's key competitors?

Who are Magellan Health's key executives?

Magellan Health's management team includes the folowing people:

  • Barry Michael Smith, Executive Chairman of the Board, Chief Executive Officer
  • Mostafa Kamal, Chief Executive Officer of Magellan Rx Management
  • Sanjeev K. Srivastava, Chief Executive Officer - Magellan Healthcare
  • Caskie R. Lewis-Clapper, Chief Human Resource Officer
  • Daniel N. Gregoire, General Counsel, Secretary
  • William J. McBride, Lead Independent Director
  • John O. Agwunobi M.D., Independent Director
  • Eran Broshy, Independent Director
  • Michael S. Diament, Independent Director
  • Perry G. Fine M.D., Independent Director

Who owns Magellan Health stock?

Magellan Health's stock is owned by a variety of of institutional and retail investors. Top institutional shareholders include BlackRock Inc. (12.70%), Vanguard Group Inc. (8.93%), Dimensional Fund Advisors LP (8.37%), Renaissance Technologies LLC (5.12%), JPMorgan Chase & Co. (3.77%) and Fisher Asset Management LLC (3.14%). Company insiders that own Magellan Health stock include Clapper Caskie Lewis, Eran Broshy, Jeffrey N West and Jonathan N Rubin. View Institutional Ownership Trends for Magellan Health.

Who sold Magellan Health stock? Who is selling Magellan Health stock?

Magellan Health's stock was sold by a variety of institutional investors in the last quarter, including Morgan Stanley, Acadian Asset Management LLC, Goldman Sachs Group Inc., Cornerstone Capital Management Holdings LLC., Systematic Financial Management LP, American Century Companies Inc., Wellington Management Group LLP and Oxford Asset Management. Company insiders that have sold Magellan Health stock in the last year include Clapper Caskie Lewis, Eran Broshy, Jeffrey N West and Jonathan N Rubin. View Insider Buying and Selling for Magellan Health.

Who bought Magellan Health stock? Who is buying Magellan Health stock?

Magellan Health's stock was acquired by a variety of institutional investors in the last quarter, including BlackRock Inc., Renaissance Technologies LLC, Vanguard Group Inc., Victory Capital Management Inc., Nationwide Fund Advisors, Dean Investment Associates LLC, JPMorgan Chase & Co. and Smith Asset Management Group LP. View Insider Buying and Selling for Magellan Health.

How do I buy Magellan Health stock?

Shares of Magellan Health can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Magellan Health's stock price today?

One share of Magellan Health stock can currently be purchased for approximately $72.65.


MarketBeat Community Rating for Magellan Health (NASDAQ MGLN)
Community Ranking:  2.5 out of 5 (  )
Outperform Votes:  157 (Vote Outperform)
Underperform Votes:  151 (Vote Underperform)
Total Votes:  308
MarketBeat's community ratings are surveys of what our community members think about Magellan Health and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for Magellan Health (NASDAQ:MGLN) (How are Consensus Ratings Calculated?)
Ratings Breakdown: 1 Sell Rating, 1 Hold Rating, 2 Buy Ratings
Consensus Rating:Hold (Score: 2.25)
Consensus Price Target: $76.67 (5.53% upside)

Analysts' Ratings History for Magellan Health (NASDAQ:MGLN)
Show:
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
6/25/2017Leerink SwannReiterated RatingOutperform$68.00 -> $73.00N/AView Rating Details
2/24/2017Jefferies Group LLCLower Price TargetBuy$89.00 -> $88.00N/AView Rating Details
11/23/2016Barclays PLCBoost Price TargetUnderweight$61.00 -> $69.00N/AView Rating Details
6/30/2016KeyCorpInitiated CoverageEqual WeightN/AView Rating Details
(Data available from 6/25/2015 forward)

Earnings

Earnings History for Magellan Health (NASDAQ:MGLN)
Earnings by Quarter for Magellan Health (NASDAQ:MGLN)
Earnings History by Quarter for Magellan Health (NASDAQ MGLN)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
7/27/2017        
4/26/2017Q1 2017$0.70$0.74$1.33 billion$1.31 billionViewN/AView Earnings Details
2/24/2017Q416$1.68$1.80$1.33 billion$1.26 billionViewN/AView Earnings Details
11/9/2016Q316$0.67$1.39$1.22 billion$1.29 billionViewListenView Earnings Details
7/29/2016Q216$0.62$0.58$1.15 billion$1.16 billionViewListenView Earnings Details
5/5/2016Q116$0.55$0.54$1.04 billion$1.12 billionViewN/AView Earnings Details
2/29/2016Q415$0.83$1.39$1.23 billion$1.27 billionViewListenView Earnings Details
10/27/2015Q315$0.49$0.53$1.19 billion$1.19 billionViewListenView Earnings Details
7/27/2015Q215$0.38$0.17$1.09 billion$1.16 billionViewListenView Earnings Details
4/30/2015Q115$0.38$0.73$1.02 billion$981.00 millionViewN/AView Earnings Details
2/26/2015Q414$0.49$1.04$980.37 million$982.50 millionViewListenView Earnings Details
10/24/2014Q314$0.44$1.09$930.10 million$823.20 millionViewListenView Earnings Details
7/25/2014Q214$0.56$0.25$863.10 million$888.00 millionViewListenView Earnings Details
4/29/2014Q114$0.75$0.92$1,000.00 million$966.50 millionViewListenView Earnings Details
3/3/2014Q413$0.83$0.67$990.55 million$1.01 millionViewN/AView Earnings Details
10/24/2013Q313$1.01$1.70$875.26 million$873.60 millionViewN/AView Earnings Details
7/25/2013Q2 2013$1.01$1.15$852.42 million$842.70 millionViewN/AView Earnings Details
4/30/2013Q1 2013$0.88$1.01$864.04 million$821.30 millionViewN/AView Earnings Details
2/28/2013Q4 2012$1.05$1.32$835.55 million$830.30 millionViewN/AView Earnings Details
10/26/2012Q312$0.96$1.12$845.16 million$798.40 millionViewN/AView Earnings Details
7/27/2012$0.91$0.97ViewN/AView Earnings Details
4/27/2012$0.90$0.75ViewN/AView Earnings Details
2/28/2012$0.77$1.05ViewN/AView Earnings Details
10/27/2011$0.84$1.03ViewN/AView Earnings Details
7/29/2011$0.86$1.07ViewN/AView Earnings Details
4/29/2011$0.79$1.02ViewN/AView Earnings Details
2/24/2011$0.91$0.95ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Magellan Health (NASDAQ:MGLN)
2017 EPS Consensus Estimate: $4.20
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20173$0.66$0.87$0.75
Q2 20173$0.85$0.93$0.90
Q3 20173$0.86$1.19$1.02
Q4 20173$1.36$1.80$1.53
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Magellan Health (NASDAQ:MGLN)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading and Institutional Ownership History for Magellan Health (NASDAQ:MGLN)
Insider Ownership Percentage: 3.60%
Institutional Ownership Percentage: 94.27%
Insider Trades by Quarter for Magellan Health (NASDAQ:MGLN)
Institutional Ownership by Quarter for Magellan Health (NASDAQ:MGLN)
Insider Trades by Quarter for Magellan Health (NASDAQ:MGLN)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
2/24/2017Jeffrey N WestSVPSell13,512$80.31$1,085,148.72View SEC Filing  
2/23/2017Eran BroshyDirectorSell4,867$80.00$389,360.00View SEC Filing  
2/3/2017Jeffrey N WestSVPSell15,055$76.46$1,151,105.30View SEC Filing  
2/1/2017Jeffrey N WestSVPSell3,346$76.05$254,463.30View SEC Filing  
12/8/2016Clapper Caskie LewisInsiderSell55,590$74.43$4,137,563.70View SEC Filing  
12/7/2016Jonathan N RubinCFOSell42,966$73.27$3,148,118.82View SEC Filing  
12/5/2016Jonathan N RubinCFOSell1,600$73.05$116,880.00View SEC Filing  
12/1/2016Jonathan N RubinCFOSell1,150$73.23$84,214.50View SEC Filing  
11/30/2016Jonathan N RubinCFOSell7,620$73.01$556,336.20View SEC Filing  
11/29/2016Jonathan N RubinCFOSell7,177$73.01$523,992.77View SEC Filing  
7/12/2016Jeffrey N WestSVPBuy267$51.99$13,881.33View SEC Filing  
1/15/2016Jeffrey N WestSVPBuy105$52.41$5,503.05View SEC Filing  
7/15/2015Jeffrey N WestSVPBuy298$50.22$14,965.56View SEC Filing  
3/19/2015Daniel N GregoireGeneral CounselSell26,232$68.47$1,796,105.04View SEC Filing  
3/16/2015Daniel N GregoireGeneral CounselSell15,528$66.80$1,037,270.40View SEC Filing  
3/16/2015Jonathan N RubinCFOSell21,270$66.59$1,416,369.30View SEC Filing  
3/13/2015Daniel N GregoireGeneral CounselSell9,765$66.21$646,540.65View SEC Filing  
3/2/2015Daniel N GregoireGeneral CounselSell20,365$64.48$1,313,135.20View SEC Filing  
6/30/2014Daniel N GregoireGeneral CounselSell21,675$62.25$1,349,268.75View SEC Filing  
6/26/2014Jonathan N RubinCFOSell29,700$61.92$1,839,024.00View SEC Filing  
6/25/2014Jonathan N RubinCFOSell18,400$62.40$1,148,160.00View SEC Filing  
6/24/2014Jonathan N RubinCFOSell19,200$62.46$1,199,232.00View SEC Filing  
6/23/2014Jonathan N RubinCFOSell21,700$62.73$1,361,241.00View SEC Filing  
6/20/2014Jonathan N RubinCFOSell31,200$62.99$1,965,288.00View SEC Filing  
6/19/2014Jonathan N RubinCFOSell18,600$62.73$1,166,778.00View SEC Filing  
6/18/2014Jonathan N RubinCFOSell35,896$62.79$2,253,909.84View SEC Filing  
6/17/2014Jonathan N RubinCFOSell23,996$62.22$1,493,031.12View SEC Filing  
6/16/2014Jonathan N RubinCFOSell13,041$62.18$810,889.38View SEC Filing  
6/16/2014Tina BlasiCEOSell10,775$62.07$668,804.25View SEC Filing  
6/13/2014Tina BlasiCEOSell10,247$62.03$635,621.41View SEC Filing  
5/19/2014Barry SmithCEOBuy10,000$58.56$585,600.00View SEC Filing  
5/14/2014Robert LeblancDirectorBuy10,000$55.60$556,000.00View SEC Filing  
3/6/2014Tina BlasiCEOSell10,527$60.42$636,041.34View SEC Filing  
12/20/2013Daniel GregoireGeneral CounselSell10,631$58.00$616,598.00View SEC Filing  
12/3/2013Rene LererChairmanSell28,321$61.01$1,727,864.21View SEC Filing  
12/2/2013Rene LererChairmanSell36,000$61.30$2,206,800.00View SEC Filing  
11/26/2013Rene LererChairmanSell5,055$60.75$307,091.25View SEC Filing  
11/22/2013Rene LererChairmanSell14,700$60.67$891,849.00View SEC Filing  
11/18/2013Rene LererChairmanSell33,215$61.34$2,037,408.10View SEC Filing  
11/14/2013Rene LererDirectorSell52,541$59.99$3,151,934.59View SEC Filing  
11/12/2013Rene LererChairmanSell36,500$59.34$2,165,910.00View SEC Filing  
11/8/2013Rene LererChairmanSell15,200$59.62$906,224.00View SEC Filing  
11/6/2013Rene LererChairmanSell96,773$59.27$5,735,735.71View SEC Filing  
11/4/2013Rene LererChairmanSell62,900$59.01$3,711,729.00View SEC Filing  
10/24/2013Tina BlasiCEOSell12,331$62.00$764,522.00View SEC Filing  
7/11/2013Jonathan N RubinCFOSell24,500$57.53$1,409,485.00View SEC Filing  
7/9/2013Jonathan N RubinCFOSell27,950$57.92$1,618,864.00View SEC Filing  
7/8/2013Jonathan N RubinCFOSell6,150$57.05$350,857.50View SEC Filing  
6/19/2013Jonathan N RubinCFOSell1,600$57.06$91,296.00View SEC Filing  
6/3/2013Clapper Caskie LewisInsiderSell43,399$55.00$2,386,945.00View SEC Filing  
5/31/2013Clapper Caskie LewisInsiderSell14,002$55.00$770,110.00View SEC Filing  
10/5/2012Tina BlasiCEOSell3,000$52.06$156,180.00View SEC Filing  
10/3/2012Tina BlasiCEOSell1,955$52.03$101,718.65View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Headline Trends for Magellan Health (NASDAQ:MGLN)
Latest Headlines for Magellan Health (NASDAQ:MGLN)
Source:
DateHeadline
americanbankingnews.com logoMagellan Health, Inc. (MGLN) Stock Rating Reaffirmed by Leerink Swann
www.americanbankingnews.com - June 25 at 11:20 AM
americanbankingnews.com logo$1.40 Billion in Sales Expected for Magellan Health, Inc. (MGLN) This Quarter
www.americanbankingnews.com - June 25 at 8:16 AM
americanbankingnews.com logo$0.96 Earnings Per Share Expected for Magellan Health, Inc. (MGLN) This Quarter
www.americanbankingnews.com - June 23 at 6:20 PM
finance.yahoo.com logoETFs with exposure to Magellan Health, Inc. : June 15, 2017
finance.yahoo.com - June 16 at 7:44 AM
americanbankingnews.com logoMagellan Health, Inc. (MGLN) Upgraded to "Hold" by BidaskClub
www.americanbankingnews.com - June 13 at 10:26 PM
americanbankingnews.com logoMagellan Health Inc (MGLN) Short Interest Up 6.3% in May
www.americanbankingnews.com - June 11 at 12:46 PM
americanbankingnews.com logoMagellan Health Inc (MGLN) Given Average Recommendation of "Hold" by Analysts
www.americanbankingnews.com - June 9 at 4:48 PM
finance.yahoo.com logoMagellan Health Provides Free Counseling Services and Resources to Individuals Impacted by Shootings at Orlando Workplace
finance.yahoo.com - June 6 at 9:30 AM
finance.yahoo.com logoMagellan Health, Inc. breached its 50 day moving average in a Bullish Manner : MGLN-US : June 2, 2017
finance.yahoo.com - June 2 at 7:54 PM
americanbankingnews.com logo$1.40 Billion in Sales Expected for Magellan Health Inc (MGLN) This Quarter
www.americanbankingnews.com - June 1 at 11:14 AM
americanbankingnews.com logoZacks: Analysts Anticipate Magellan Health Inc (MGLN) Will Post Earnings of $0.96 Per Share
www.americanbankingnews.com - May 30 at 2:10 PM
finance.yahoo.com logoMagellan Health, Inc. breached its 50 day moving average in a Bearish Manner : MGLN-US : May 19, 2017
finance.yahoo.com - May 19 at 11:05 AM
finance.yahoo.com logo[$$] Frazier Healthcare Adds Senior Adviser
finance.yahoo.com - May 16 at 6:20 PM
americanbankingnews.com logoMagellan Health Inc (MGLN) Receives Consensus Rating of "Hold" from Analysts
www.americanbankingnews.com - May 15 at 12:46 PM
finance.yahoo.com logoPost Earnings Coverage as Aetna's Adjusted EPS Jumped 17%
finance.yahoo.com - May 15 at 10:26 AM
finance.yahoo.com logoMagellan Health to Participate in Jefferies 2017 Global Healthcare Conference
finance.yahoo.com - May 11 at 7:00 PM
finance.yahoo.com logoMagellan Health to Present at Barclays Pharmacy Benefit Management & Drug Pricing Symposium
finance.yahoo.com - May 9 at 11:49 AM
americanbankingnews.com logo$0.88 Earnings Per Share Expected for Magellan Health Inc (MGLN) This Quarter
www.americanbankingnews.com - May 4 at 8:32 PM
americanbankingnews.com logoBrokers Offer Predictions for Magellan Health Inc's FY2018 Earnings (MGLN)
www.americanbankingnews.com - May 4 at 7:06 PM
finance.yahoo.com logoMagellan Health, Inc. breached its 50 day moving average in a Bearish Manner : MGLN-US : May 4, 2017
finance.yahoo.com - May 4 at 11:39 AM
americanbankingnews.com logoMagellan Health (MGLN) Earns Daily Media Sentiment Rating of 0.37
www.americanbankingnews.com - May 3 at 7:42 PM
finance.yahoo.com logoETFs with exposure to Magellan Health, Inc. : May 1, 2017
finance.yahoo.com - May 1 at 5:32 PM
americanbankingnews.com logoMagellan Health Inc to Post Q2 2017 Earnings of $0.85 Per Share, Jefferies Group Forecasts (MGLN)
www.americanbankingnews.com - May 1 at 7:54 AM
americanbankingnews.com logoZacks Investment Research Upgrades Magellan Health Inc (MGLN) to "Hold"
www.americanbankingnews.com - April 30 at 7:59 PM
americanbankingnews.com logoMagellan Health (MGLN) Earns Daily Media Impact Rating of 0.56
www.americanbankingnews.com - April 30 at 10:22 AM
finance.yahoo.com logoMagellan Health, Inc. :MGLN-US: Earnings Analysis: Q1, 2017 By the Numbers : April 28, 2017
finance.yahoo.com - April 28 at 7:27 PM
americanbankingnews.com logoMagellan Health Inc (MGLN) Upgraded to Hold at Zacks Investment Research
www.americanbankingnews.com - April 28 at 7:04 PM
americanbankingnews.com logoQ3 2017 Earnings Forecast for Magellan Health Inc (MGLN) Issued By Jefferies Group
www.americanbankingnews.com - April 28 at 1:22 PM
finance.yahoo.com logoEdited Transcript of MGLN earnings conference call or presentation 26-Apr-17 2:00pm GMT
finance.yahoo.com - April 27 at 7:04 PM
americanbankingnews.com logoMagellan Health (MGLN) Earning Very Positive Press Coverage, Study Finds
www.americanbankingnews.com - April 27 at 10:02 AM
finance.yahoo.com logoMagellan Health Reports First Quarter 2017 Financial Results
finance.yahoo.com - April 26 at 6:47 PM
americanbankingnews.com logoMagellan Health Inc (MGLN) Releases Earnings Results, Beats Estimates By $0.04 EPS
www.americanbankingnews.com - April 26 at 2:26 PM
marketbeat.com logoMagellan Health tops 1Q profit forecasts
marketbeat.com - April 26 at 11:40 AM
finance.yahoo.com logoMagellan Health, Inc. – Value Analysis (NASDAQ:MGLN) : April 25, 2017
finance.yahoo.com - April 25 at 5:50 PM
finance.yahoo.com logoMagellan Health, Inc. breached its 50 day moving average in a Bullish Manner : MGLN-US : April 24, 2017
finance.yahoo.com - April 24 at 3:07 PM
americanbankingnews.com logoMagellan Health (MGLN) Given Daily Coverage Optimism Score of 0.48
www.americanbankingnews.com - April 22 at 9:13 AM
finance.yahoo.com logoMagellan Rx Management Earns URAC Reaccreditation in Pharmacy Benefit Management
finance.yahoo.com - April 21 at 9:58 AM
americanbankingnews.com logoVery Favorable Press Coverage Extremely Likely to Affect Magellan Health (MGLN) Stock Price
www.americanbankingnews.com - April 19 at 8:01 AM
americanbankingnews.com logoMagellan Health Inc (MGLN) Receives Consensus Recommendation of "Hold" from Analysts
www.americanbankingnews.com - April 18 at 1:45 PM
finance.yahoo.com logoTMG by Magellan Health to Expand Statewide in Wisconsin
finance.yahoo.com - April 18 at 10:25 AM
americanbankingnews.com logoMagellan Health Inc (MGLN) to Post Q1 2017 Earnings of $0.72 Per Share, Leerink Swann Forecasts
www.americanbankingnews.com - April 18 at 10:15 AM
americanbankingnews.com logoMagellan Health (MGLN) Receives Daily Media Sentiment Rating of 0.56
www.americanbankingnews.com - April 15 at 9:00 AM
americanbankingnews.com logo$1.36 Billion in Sales Expected for Magellan Health Inc (MGLN) This Quarter
www.americanbankingnews.com - April 15 at 8:32 AM
americanbankingnews.com logo Brokerages Expect Magellan Health Inc (MGLN) to Post $0.72 Earnings Per Share
www.americanbankingnews.com - April 13 at 4:17 PM
americanbankingnews.com logoMagellan Health Inc (MGLN) Cut to Sell at Zacks Investment Research
www.americanbankingnews.com - April 8 at 7:34 AM
finance.yahoo.com logoMagellan Rx Management’s Medical Pharmacy Trend Report Highlights Member and Payer Impact of High-Cost Specialty Drugs Billed on the Medical Benefit
finance.yahoo.com - April 3 at 10:17 AM
finance.yahoo.com logoMagellan Health Announces First Quarter 2017 Earnings Conference Call
finance.yahoo.com - March 28 at 10:28 AM
americanbankingnews.com logoMagellan Health Inc (MGLN) Given Consensus Rating of "Hold" by Brokerages
www.americanbankingnews.com - March 24 at 1:53 PM
finance.yahoo.com logoMagellan Behavioral Health of Pennsylvania, Inc. Earns Full Accreditation from the National Committee for Quality Assurance
finance.yahoo.com - March 23 at 7:04 PM
finance.yahoo.com logoShould Value Investors Consider Magellan Health Stock?
finance.yahoo.com - March 22 at 6:38 PM

Social

Chart

Magellan Health (MGLN) Chart for Sunday, June, 25, 2017

This page was last updated on 6/25/2017 by MarketBeat.com Staff